SCHEMBL26089762

SCHEMBL26089762

Cc1cc(-c2nc3ccncc3[nH]2)cs1

nearest known ligand 0.65

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 5/20 0.55
KDM4E B2RXH2 5/20 0.55
HPGD P15428 3/20 0.55
PKM P14618 2/20 0.55
NPC1 O15118 2/20 0.55
RAB9A P51151 2/20 0.55
SMN1; SMN2 Q16637 1/20 0.55
AURKA O14965 1/20 0.55
METAP1 P53582 2/20 0.51
HPSE Q9Y251 1/20 0.48
METAP2 P50579 1/20 0.47
PDE5A O76074 2/20 0.46
NPY5R Q15761 1/20 0.46
PKN1 Q16512 1/20 0.45
PKN2 Q16513 1/20 0.45
ADORA3 P0DMS8 1/20 0.45
JMJD6 Q6NYC1 1/20 0.44
RPS6KA5 O75582 1/20 0.44
LDHA P00338 1/20 0.42
EPHX2 P34913 1/20 0.42

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16331618 0.77 ALDH1A1 (0.71) ALDH1A1KDM4EHPGDPKMNPC1
SCHEMBL5591276 0.77 ALDH1A1 (0.62) ALDH1A1KDM4EHPGDPKMNPC1
Hydrochloric Acid SCHEMBL5591487 0.76 ALDH1A1 (0.61) ALDH1A1KDM4EHPGDPKMNPC1
SCHEMBL1170780 0.76 ALDH1A1 (0.68) ALDH1A1KDM4EHPGDPKMNPC1
SCHEMBL26426691 0.75 ALDH1A1 (0.65) ALDH1A1KDM4EHPGDPKMNPC1
SCHEMBL26426692 0.74 PDE5A (0.52) ALDH1A1KDM4EHPGDPKMNPC1
SCHEMBL28725349 0.74 ALDH1A1 (0.62) ALDH1A1KDM4EHPGDPKMNPC1
SCHEMBL3331253 0.73 ALDH1A1 (0.71) ALDH1A1KDM4EHPGDPKMNPC1
SCHEMBL14815177 0.73 ALDH1A1 (0.66) ALDH1A1KDM4EHPGDPKMNPC1
SCHEMBL5591384 0.72 ALDH1A1 (0.59) ALDH1A1KDM4EHPGDPKMNPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12577242-B2 Pyrrolopyridine and imidazopyridine antiviral compounds KATHOLIEKE UNIVERSITEIT LEUVEN (BE) 2026-03-17 US disclosed
US-20230130598-A1 PYRROLOPYRIDINE AND IMIDAZOPYRIDINE ANTIVIRAL COMPOUNDS KATHOLIEKE UNIVERSITEIT LEUVEN (BE) 2023-04-27 US disclosed
US-20230130598-A1 PYRROLOPYRIDINE AND IMIDAZOPYRIDINE ANTIVIRAL COMPOUNDS KATHOLIEKE UNIVERSITEIT LEUVEN (BE) 2023-04-27 US disclosed
US-20230130598-A1 PYRROLOPYRIDINE AND IMIDAZOPYRIDINE ANTIVIRAL COMPOUNDS KATHOLIEKE UNIVERSITEIT LEUVEN (BE) 2023-04-27 US disclosed
EP-4110777-A1 PYRROLOPYRIDINE AND IMIDAZOPYRIDINE ANTIVIRAL COMPOUNDS Katholieke Universiteit Leuven, K.U.Leuven R&D (BE) 2023-01-04 EP disclosed
CN-115175909-A Pyrrolopyridine and imidazopyridine antiviral compounds 鲁汶天主教大学 2022-10-11 CN disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230130598-A1 PYRROLOPYRIDINE AND IMIDAZOPYRIDINE ANTIVIRAL COMPOUNDS SARS1, TPI1, TPMT ALDH1A1 1430/4885KDM4E 3519/4885HPGD 3637/4885
US-12577242-B2 Pyrrolopyridine and imidazopyridine antiviral compounds SARS1, TPMT, ZC3HAV1 ALDH1A1 3438/4885KDM4E 612/4885HPGD 4049/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.